CASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare Conference

Rhea-AI Summary

CASI Pharmaceuticals, a U.S. biopharmaceutical company, announced that Dr. Wei-Wu He will present at the Jefferies Virtual Healthcare Conference on June 4, 2021, at 9:30 AM (EST). The event will showcase the company’s focus on developing therapeutics in hematology oncology and other unmet medical needs. A webcast will be available on CASI's website in the 'Investors Relations' section, with replays for 30 days post-event. CASI aims to leverage its expertise in China and the U.S. to become a leader in the biopharmaceutical industry.

ROCKVILLE, Md. and BEIJING, May 27, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that Dr. Wei-Wu He, Chairman and Chief Executive Officer of CASI Pharmaceuticals, will be presenting at the Jefferies Virtual Healthcare Conference. Details for the virtual conferences are as follows.

Jefferies Virtual Healthcare Conference
Date: Friday, June 4^th
Time: 9:30 AM (EST)

Webcast or external link of the company presentations will be available under "Events & Presentations" in the "Investors Relations" section of CASI's website. Archived replays will be available for approximately 30 days following the event.

About CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the greater China market leveraging the Company's China-based regulatory and commercial competencies and its global drug development expertise. The Company's operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd., which is located in Beijing, China. The Company has built a commercial team of more than 80 hematology and oncology sales and marketing specialists based in China. More information on CASI is available at www.casipharmaceuticals.com.

COMPANY CONTACT: CASI Pharmaceuticals, Inc. 240.864.2643 ir@casipharmaceuticals.com

INVESTOR CONTACT: Solebury Trout Bob Ai 646-378-2926 bai@soleburytrout.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/casi-pharmaceuticals-inc-to-participate-in-jefferies-virtual-healthcare-conference-301300576.html

SOURCE CASI Pharmaceuticals, Inc.

FAQ

What date will CASI Pharmaceuticals present at the Jefferies Virtual Healthcare Conference?

CASI Pharmaceuticals will present at the Jefferies Virtual Healthcare Conference on June 4, 2021.

What time is CASI Pharmaceuticals' presentation at the Jefferies Conference?

The presentation will take place at 9:30 AM (EST) on June 4, 2021.

Where can I watch the CASI Pharmaceuticals presentation?

You can watch the CASI Pharmaceuticals presentation on their website under the 'Investors Relations' section.

How long will the CASI Pharmaceuticals conference replay be available?

The archived replay of the CASI Pharmaceuticals conference will be available for approximately 30 days after the event.

Who is the CEO of CASI Pharmaceuticals?

The CEO of CASI Pharmaceuticals is Dr. Wei-Wu He.

What is the focus of CASI Pharmaceuticals?

CASI Pharmaceuticals focuses on developing and commercializing innovative therapeutics, primarily in hematology oncology.